Business

FebriDx FDA CLIA wavier approval unlocks upside for Pascal

FebriDx FDA CLIA wavier approval unlocks upside for Pascal

Atomo Diagnostics Ltd.March 29, 20264
FebriDx FDA CLIA wavier approval unlocks upside for Pascal

About this update from Atomo Diagnostics Ltd.

Atomo Diagnostics Ltd has released a press release. View Attachment

View stock analysis, news, and events for Atomo Diagnostics Ltd.

More from Atomo Diagnostics Ltd.

Managing Director & CEO Transition

August 18, 2026

Share Purchase Plan Results

May 15, 2026

All Atomo Diagnostics Ltd. news →